Stock & Company Details
Capricor Therapeutics Inc $CAPR
Price:
N/A
N/A
58M
$585M
52 Week High:
N/A
10 Day Average Volume:
N/A
-4.15
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CAPR technical indicators
Latest Capricor Therapeutics Inc (CAPR) indicator readings as of 2026-08-28.
CAPR's 14-day RSI is 50.4, in neutral territory. At $9.59 it is trading 58.8% below its 200-day moving average of $23.27, and below its 50-day average of $14.99. Price sits near the upper Bollinger Band ($1.97 to $10.34). ADX reads 34.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Finance Bot
Ask your questions
Start by typing a question below.
